Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PAX.STthis companyPaxman AB (publ)	SEK 62.80	-73.95×	3.05×	3.95×	39.69×	-30.1%	66.6%	1.4%	-5.3%	-4.1%	1.0%	-1.3%	0.03×	-3.79×	4.28×	3.97×	0.0%	2	13.71	2	C+
BICO.STBICO Group AB (publ)	SEK 23.75	-1.36×	0.85×	0.99×	-48.97×	-130.1%	38.9%	-16.8%	-72.7%	-62.3%	-7.9%	3.7%	0.86×	-6.38×	-0.78×	1.27×	0.0%	6	-2.84	3	B-
CRAD-B.STC-Rad AB (publ)	SEK 23.60	103.06×	3.12×	2.45×	16.63×	-54.3%	69.2%	10.2%	2.4%	3.0%	8.3%	4.6%	0.03×	-2.92×	49.18×	3.09×	0.0%	4	5.23	4	A-
DMYD-B.STDiamyd Medical AB (publ)	SEK 0.98	-0.58×	0.61×	310.44×	0.62×	98.3%	-478.8%	-54562.9%	-53583.4%	-104.9%	-78.6%	-132.6%	0×	1.21×	-73.88×	9.08×	0.0%	3	-0.68	2	B-
GENO.STGenovis AB	SEK 21.00	59.03×	5.15×	10.84×	34.56×	-59.9%	21.3%	21.3%	18.2%	8.7%	6.8%	2.2%	0.52×	-0.59×	7.29×	7.36×	0.0%	4	8.04	3	B-
OSSD.STOssDsign AB (publ)	SEK 3.91	-24.65×	4.04×	6.95×	-23.99×	-4832.4%	96.3%	-26.8%	-28.3%	-16.4%	-13.3%	-5.7%	0×	4.29×	-1,051.26×	6.97×	0.0%	0	0.72	2	C+
Peer median	—	-0.58×	3.12×	6.95×	0.62×	-59.9%	38.9%	-16.8%	-28.3%	-16.4%	-7.9%	2.2%	0.03×	-0.59×	-0.78×	6.97×	0.0%	4	0.72	3	—